investor.cempra.com investor.cempra.com

investor.cempra.com

Cempra - Investor Relations

Change: - 1.23. Day High: 41.49. Day Low: 38.75. 4:00 PM ET Aug 7, 2015. Delayed 20 min., by eSignal. Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibacterials to meet critical medical needs. Two lead antibacterial products, both in the treatment of infectious diseases, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. View all ». Aug 4, 2015. Jul 29, 2015. View all ».

http://investor.cempra.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTOR.CEMPRA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.7 out of 5 with 17 reviews
5 star
5
4 star
6
3 star
4
2 star
0
1 star
2

Hey there! Start your review of investor.cempra.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

CONTACTS AT INVESTOR.CEMPRA.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Cempra - Investor Relations | investor.cempra.com Reviews
<META>
DESCRIPTION
Change: - 1.23. Day High: 41.49. Day Low: 38.75. 4:00 PM ET Aug 7, 2015. Delayed 20 min., by eSignal. Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibacterials to meet critical medical needs. Two lead antibacterial products, both in the treatment of infectious diseases, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. View all ». Aug 4, 2015. Jul 29, 2015. View all ».
<META>
KEYWORDS
1 preclinical trials
2 news and events
3 investor relations
4 overview
5 press releases
6 events and presentations
7 corporate governance
8 management
9 board of directors
10 committee composition
CONTENT
Page content here
KEYWORDS ON
PAGE
preclinical trials,news and events,investor relations,overview,press releases,events and presentations,corporate governance,management,board of directors,committee composition,financial information,sec filings,annual reports,quarterly results,nasdaq cemp
SERVER
nginx
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Cempra - Investor Relations | investor.cempra.com Reviews

https://investor.cempra.com

Change: - 1.23. Day High: 41.49. Day Low: 38.75. 4:00 PM ET Aug 7, 2015. Delayed 20 min., by eSignal. Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibacterials to meet critical medical needs. Two lead antibacterial products, both in the treatment of infectious diseases, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. View all ». Aug 4, 2015. Jul 29, 2015. View all ».

INTERNAL PAGES

investor.cempra.com investor.cempra.com
1

Cempra - Analyst Coverage

http://investor.cempra.com/analysts.cfm

Day High: 22.00. Day Low: 20.77. 4:00 PM ET Aug 26, 2016. Delayed 20 min., by eSignal. Eun K Yang, Ph.D. Ladenburg Thalmann and Co. Robert C. Hazlett. Andrew Berens, M.D. Alan Carr, Ph.D. Robert W. Baird and Co. Brian P. Skorney. Debjit Chattopadhyay, Ph.D. Site design and layout by BFW Interactive.

2

Cempra Reports Second Quarter 2015 Financial Results and Provides Corporate Update (NASDAQ:CEMP)

http://investor.cempra.com/releasedetail.cfm?ReleaseID=924575

Laquo; Previous Release. Next Release ». July 29, 2015. Cempra Reports Second Quarter 2015 Financial Results and Provides Corporate Update. Management to Host Webcast and Conference Call Today at 4:30 pm EDT. CHAPEL HILL, N.C. July 29, 2015. Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported financial results for the quarter ended. June 30, 2015. And the solithromycin earl...

3

Cempra - Quarterly Results

http://investor.cempra.com/results.cfm

Day High: 22.00. Day Low: 20.77. 4:00 PM ET Aug 26, 2016. Delayed 20 min., by eSignal. Cempra Reports Second Quarter 2016 Financial Results and Provides Corporate Update. Cempra Reports First Quarter 2016 Financial Results and Provides Corporate Update. Cempra Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update. Cempra Reports Third Quarter 2015 Financial Results and Provides Corporate Update. Cempra, Inc. Reports First Quarter 2014 Financial and Operating Results.

4

Cempra - SEC Filings

http://investor.cempra.com/sec.cfm

Day High: 22.00. Day Low: 20.77. 4:00 PM ET Aug 26, 2016. Delayed 20 min., by eSignal. Aug 23, 2016. Aug 12, 2016. Aug 12, 2016. Aug 11, 2016. Bluth, john d. Aug 8, 2016. Aug 4, 2016. Aug 1, 2016. Aug 1, 2016. Jul 6, 2016. Jun 28, 2016. Jun 28, 2016. Jun 23, 2016. Jun 17, 2016. May 25, 2016. May 19, 2016. May 16, 2016. Prospectus filed pursuant to rule 424. May 6, 2016. May 6, 2016. May 2, 2016. May 2, 2016. Showing 1-20 of 293. Add PDF file to Briefcase. Site design and layout by BFW Interactive.

5

Cempra Presenting Additional Data From the Phase 3 Oral Solithromycin Study in Community Acquired Bacterial Pneumonia at the American Thoracic Society Conference (NASDAQ:CEMP)

http://investor.cempra.com/releasedetail.cfm?ReleaseID=913806

Laquo; Previous Release. Next Release ». May 19, 2015. Cempra Presenting Additional Data From the Phase 3 Oral Solithromycin Study in Community Acquired Bacterial Pneumonia at the American Thoracic Society Conference. CHAPEL HILL, N.C. May 19, 2015. And the solithromycin early clinical response (ECR) and short term follow-up (SFU) rates were numerically higher than moxifloxacin in the elderly, the patients at greatest risk for. American Thoracic Society (ATS) International Conference. We believe it is cr...

UPGRADE TO PREMIUM TO VIEW 16 MORE

TOTAL PAGES IN THIS WEBSITE

21

LINKS TO THIS WEBSITE

careers-cempra.icims.com careers-cempra.icims.com

Careers - Cempra

https://careers-cempra.icims.com/about

Site design and layout by BFW Interactive.

careers-cempra.icims.com careers-cempra.icims.com

Careers - Cempra

https://careers-cempra.icims.com/preclinical-programs

Site design and layout by BFW Interactive.

cempra.com cempra.com

Solithromycin - TAKSTA (sodium fusidate) - Cempra

http://www.cempra.com/about

Partners and Business Development. Addressing the need for differentiated antibiotics that act against drug-resistant bacteria. Cempra has two antibiotic candidates, solithromycin (CEM-101) and TAKSTA™ (CEM-102, sodium fusidate), in clinical trials. Both target the growing problem of antimicrobial resistance. Led by an accomplished management team dedicated to shape the future of the company and the industry. Cempra is led by a management team with extensive drug development and commercialization experie...

cempra.com cempra.com

differentiated antibiotics - Cempra

http://www.cempra.com/products

Antibiotic-resistant bacterial pathogens have been a rising threat to human health for several years. Effectiveness of many antibacterial agents has declined worldwide limiting physicians options to treat serious infections. Antibiotic drug resistance has a significant impact on morbidity and mortality and contributes heavily to healthcare system costs worldwide. The World Health Organization has stated that antibiotic resistance is one of the greatest healthcare challenges for the future.

cempra.com cempra.com

macrolides - Non-Antibacterial Preclinical Candidates - Cempra

http://www.cempra.com/preclinical-programs

Macrolides are a class of compounds that have historically yielded safe and highly effective antibiotics but also have potential against a range of non-infectious diseases. LEARN MORE. Cempra has identified several candidates from its macrolide library that have potential to treat inflammatory, endocrine and gastrointestinal motility disorders. LEARN MORE. Research On Non-Antibacterial Candidates. Site design and layout by BFW Interactive.

cempra.com cempra.com

Page Not Found - Cempra

http://www.cempra.com/Cempra

This page you are looking for has either moved or does not exist. Please continue with the site here. Site design and layout by BFW Interactive.

cempra.com cempra.com

differentiated antibiotics - Cempra

http://cempra.com/news

Cempra Appoints Dr. David Zaccardelli to Board of Directors. Cempra Reports Second Quarter 2016 Financial Results and Provides Corporate Update. Cempra Appoints John Bluth Executive Vice President, Investor Relations and Corporate Communications. Cempra to Report Second Quarter 2016 Financial Results. Site design and layout by BFW Interactive.

careers-cempra.icims.com careers-cempra.icims.com

Careers - Cempra

https://careers-cempra.icims.com/products

Site design and layout by BFW Interactive.

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

10

SOCIAL ENGAGEMENT



OTHER SITES

investor.cavotec.com investor.cavotec.com

Investor Relations | Cavotec SA

Service for Ports and Maritime. Underground Mining and Tunnelling. Energy, Processing and Transportation. Service for Industry and Mining. Service for Oil and Gas. Board, Group CEO and EMT Members. Board, Group CEO and EMT Members. Welcome to Cavotecs Investor Relations home page. On these pages you will find detailed reports, figures and other materials relating to the performance of the Cavotec share, the Groups corporate governance and Cavotec as a whole. Engelska är koncernens arbetsspråk&...

investor.cbrlgroup.com investor.cbrlgroup.com

Investor Relations | Cracker Barrel Old Country Store

Skip to main navigation. Get on Wait List. Please enter a valid zip code or City and State. Ex: 37087 or Lebanon, TN. Set as My Location. Get on Wait list. This field is required. Please Note: This is not a reservation. You will be added to our Wait List, although you may have a short wait when you arrive while we get ready for you. This field is required. This field requires 10 digits. Sign up for Cracker Barrel emails. I have reviewed and accepted the Terms of Use. This field is required. Message and d...

investor.ccej.co.jp investor.ccej.co.jp

Investor Relations Home | Investor Relations | COCA-COLA EAST JAPAN Co, Ltd.

Main text of this page. List of links for Terms of Use, etc. for this website. List of links for each category. In Preparation for 2020. In Preparation for 2020. Largest Coca-Cola bottler in Japan. Message from Management (Q1 2015). Q1 2015 Earnings Presentation/Webcast. Introduction of Coca-Cola East Japan. Renewal of AQUARIUS zero. About Coca-Cola East Japan. Coca-Cola East Japan One Roadmap for Growth. FY 2014 Earnings Presentation Materials. Notice of Absorption-type Merger of Consolidated Subsidiary.

investor.cdti.com investor.cdti.com

Investor Home | CDTi Advanced Materials, Inc.

Skip to main navigation. CDTi Advanced Materials, Inc. Mar 29, 2018. CDTi Advanced Materials, Inc., or "CDTi", (Nasdaq: CDTI) manufactures and distributes vehicle emissions control products that leverage its advanced materials technology. CDTi utilizes its proprietary patented Mixed Phase Catalyst (MPC. Technology and other related technologies to provide high-value sustainable solutions to reduce emissions, increase energy efficiency and lower the carbon intensity of on- and off-road combustion engine s...

investor.cdw.com investor.cdw.com

CDW Investor Relations

People Who Get IT. How We Do IT. Click Here ». CDW's success is built on the trust we have earned from our customers, coworkers, business partners, investors and communities, and trust sustains our success. Our commitment to these standards continues to be a fundamental strength of our culture and our generation. Click Here ». Aug 12, 2015. CDW Corporation Announces Pricing of Public Offering by Selling Stockholders and Repurchase of Its Common Stock. Aug 12, 2015. Aug 12, 2015. Annual Report and Proxy.

investor.cempra.com investor.cempra.com

Cempra - Investor Relations

Change: - 1.23. Day High: 41.49. Day Low: 38.75. 4:00 PM ET Aug 7, 2015. Delayed 20 min., by eSignal. Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibacterials to meet critical medical needs. Two lead antibacterial products, both in the treatment of infectious diseases, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. View all ». Aug 4, 2015. Jul 29, 2015. View all ».

investor.ceres.net investor.ceres.net

Ceres, Inc. - Investor Relations

News and Press Releases. Stock Quote (NASDAQ: CERE). 4:00 PM ET on Aug 7, 2015. Delayed at least 20 mins. Provided by eSignal. View all ». Jul 27, 2015. Ceres Announces Pricing of $1.5 Million Financing. Jul 10, 2015. Ceres Announces Fiscal Third Quarter 2015 Financial Results.

investor.cerus.com investor.cerus.com

Q4 Web Site Development

Q4 Web Maintenance Message. This site is currently under development and not yet available for public viewing. For more information on why this site is not available, please contact Q4.

investor.cfaogroup.com investor.cfaogroup.com

CFAO GROUP - Finance

CFAO GROUP - Distributor of brands. CFAO FMCG INDUSTRIES and DISTRIBUTION. Welcome to the Investor Section of the Website. 31 Jul. 2015. 04 May. 2015. 23 Feb. 2015. 2014 Annual Results - 2014 Fourth-Quarter Revenue. Mergers and Acquisition Announcement. 2015 H1 Interim Report. Leader in specialized distribution in Africa and french overseas collectivities. CFAO GROUP - Distributor of brands. CFAO FMCG INDUSTRIES and DISTRIBUTION.

investor.cgd.co.th investor.cgd.co.th

Country Group Development

Transparency is not just a requirement of good corporate governance; it’s the foundation of trust between shareholders and management. Country Group Development has a policy of providing clear and effective shareholder communications that aim to not only keep our investors fully informed, but fully engaged with the decisions and data that create the basis of our operations. Stock Information More Info. 12 Jan 2017 16:37. SET Announcement View All. Notification on the Holidays for the year 2017.

investor.cgsec.co.th investor.cgsec.co.th

Country Group Securities Public Company Limited

June 03, 2015. SOCIAL SCENE: LUXURY DINNER. May 18, 2015. SOCIAL SCENE: THANK YOU PARTY. CGS Extraordinary General Meeting No. 1/2014. Financial Statement Yearly 2015. Annual General Meeting 2014. IR-CGS@sec.countrygroup.co.th. Contact No : 0-2205-7000 Customer Service : 0-2205-7111 Fax : 0-2205-7019 E-mail: cgsetrade@countrygroup.co.th.